Abstract. Testicular germ cell tumors (TGCT) represent the most common malignant tumor group in the age group of 20 to 40-years old men. The potentially curable effect of cytotoxic therapy in TGCT is mediated mainly by the induction of apoptosis. Autophagy has been discussed as an alternative mechanism of cell death but also of treatment resistance in various types of tumors. However, in TGCT the expression and role of core autophagy-associated factors is hitherto unknown. We designed the study in order to evaluate the potential role of autophagy-associated factors in the development and progression of testicular cancers. Eighty-four patients were assessed for autophagy (BAG3, p62) and apoptosis (cleaved caspase 3) markers using immunohistochemistry (IHC) on tissue microarrays. In addition, western blot analyses of frozen tissue of seminoma and non-seminoma were performed. Our findings show that BAG3 was significantly upregulated in seminoma as compared to non-seminoma but not to normal testicular tissue. No significant difference of p62 expression was detected between neoplastic and normal tissue or between seminoma and non-seminoma. BAG3 and p62 showed distinct loco-regional expression patterns in normal and neoplastic human testicular tissues. In contrast to the autophagic markers, apoptosis rate was significantly higher in testicular tumors as compared to normal testicular tissue, but not between different TGCT subtypes. The present study, for the first time, examined the expression of central autophagy proteins BAG3 and p62 in testicular cancer. Our findings imply that in general apoptosis but not autophagy induction differs between normal and neoplastic testis tissue.
IntroductionThe effect of cytotoxic treatment in testicular tumors is mainly moderated by the induction of apoptosis (1). Due to the rapid response after exposure to chemotherapeutic agents an intact and effective apoptotic pathway in most testicular cancers is assumed (2). Nevertheless, various patients show complex clinical courses, including tumors with chemoresistence and thus lower apoptosis rates (3). Recent studies have shown that the elimination of cells may be also conducted using the alternative cell death pathway ʻautophagyʼ (4,5).Autophagy is an evolutionarily conserved, pervasive and multi-step ʻself-eatingʼ process, by which cytosolic material is sequestered in a double-lipid membrane, delivered to the lysosome for degradation and digested to provide energy and to build the foundation for cell-survival (6). While autophagy has for long been considered to be a bulk degradation process, recent discoveries show that it rather displays a sophisticated portfolio of selectivity provided by different molecular strategies such as the detection of several autophagy receptor proteins, including pacemaker molecules such as p62 (SQSTM1) and BCL2-associated athanogene 3 (BAG3) (7-9). To the best of our knowledge, no study has been published to date that examined the expression of the cohesive autophagy proteins BAG3 and p62 in testicular can...